Live·Verified funding discovery · 2026.2

874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640

△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA

Maxim Skulachev

individual

Ecosystem influencer

About

Maxim Skulachev is a biotech scientist focused on mitochondria-targeted therapeutics and age-related disease biology. He serves as Chief Scientific Officer of Mitotech, where he oversees core scientific research around the company's SkQ1 platform. Public sources also link his research career to Moscow State University and Icon Genetics GmbH.

Areas of interest

longevitybiotechmitochondrial biologydrug discoveryophthalmologyage-related disordersneurodegenerative disordersmetabolic diseases